Thursday, November 18, 2010 5:16:11 PM
Found this twist to the story:
March 1, 2007
Peregrine recently announced that it had established a wholly foreign-owned enterprise (WFOE) in the People’s Republic of China. The new subsidiary, Peregrine Beijing Pharmaceuticals Technology Development Ltd., is expected to engage in a variety of drug development and commercialization activities.
http://healthplanet.wordpress.com/category/lung-cancer/page/19/
Strange
And:
Other Developments
-- Peregrine settled a lawsuit with Cancer Therapeutics Laboratories (CTL).
Under the terms of the agreement, CTL is transferring shares in
Medibiotech Co., Inc. to Peregrine, giving Peregrine close to a 5%
ownership stake in Medibiotech. Medibiotech is a Chinese company that
has the exclusive rights in the People's Republic of China to
develop and market a version of Peregrine's radiolabeled tumor
necrosis therapy (TNT) technology for the treatment of cancer.
Peregrine will also make certain cash payments to CTL.
(Why no updates, CTL is private)?
FEATURED Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
